Abstract:
The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
Abstract:
The present invention relates to compounds of formula (I) useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
Abstract:
Described herein are compounds that are useful as caspase inhibitors having the formula (I):wherein Ring A is an optionally substituted piperidine, tetrahydorquinoline or tetrahydroisoquinoline ring; R is hydrogen, CN, CHN , R, or CH Y; R is an optionally substituted group selected from an aliphatic group, an aryl group, or an aralkyl group; Y is an electronegative leaving group; R is CO H, CH CO H, or esters, amides or isosteres thereof; and R is hydrogen, an optionally substituted aryl group, and optionally substituted aralkyl group, or an optionally substituted C1-6 aliphatic group, R is an optionally substituted group selected from an aryl group or a heterocycle group, or R and R taken toegether with the nitrogen to which they are attached optionally form a substituted or unsubstituted monocyclic, bicyclic or tricyclic ring.
Abstract translation:本文描述了可用作具有式(I)的半胱天冬酶抑制剂的化合物:其中环A是任选取代的哌啶,四氢喹啉或四氢异喹啉环; R 1是氢,CN,CHN 2,R或CH 2 Y; R是选自脂族基团,芳基或芳烷基的任选取代的基团; Y是电负离子团; R 2是CO 2 H,CH 2 CO 2,或它们的酯,酰胺或其等价物; 和R 3是氢,任选取代的芳基和任选取代的芳烷基,或任选取代的C 1-6脂族基团,R 4是任选取代的选自芳基或杂环基团,或 R 3和R 4与它们所连接的氮一起取代任选地形成取代或未取代的单环,双环或三环。
Abstract:
The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula (I); or a pharmaceutically acceptable salt, wherein the variables R1, R2, R3, and R4 are as defined herein.
Abstract:
The present invention provides a compound of formula (I), wherein R , R C(O)-, HC(O)-, R SO2-, R OC(O)-, (R )2NC(O)-, (R ) (H) NC (O)-, R C (O) C (O) -, R -, (R ) 2NC (O) C (O)-, R (H) NC (O) C (O)-, or R OC (O) C (O)-; R is hydrogen, CF3, -halo, -OR , -NO2, -OCF3, -CN, or R ; R is hydrogen or (C1-C4) -aliphatic-; R is -COOH or -COOR ; R is -CH2F or -CH2O-2, 3, 5, 6-tetrafluorophenyl. The present invention also provides pharmaceutical compositions and methods using such compositions for treating a caspase-mediated diseases and processes for preparing the compounds of the invention.
Abstract:
The invention relates to molecules or molecular complexes which comprise binding pockets of ITK or its structural homologues. The invention relates to crystallizable compositions and crystals comprising ITK. The present invention also relates to a data storage medium encoded with the structural coordinates of molecules and molecular complexes which comprise the ITK or ITK-like ATP-binding pockets. The present invention also relates to a computer comprising such data storage material. The computer may generate a three-dimensional structure or graphical three-dimensional representation of such molecules or molecular complexes. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to ITK or homologues thereof.
Abstract:
The present invention provides crystalline molecules or molecular complexes which comprise binding pockets of Aurora-2 or its homologues. The invention also provides crystals comprising Aurora-2. The present invention also relates to a computer comprising a data storage medium encoded with the structural coordinates of Aurora-2 binding pockets and methods of using a computer to evaluate the ability of a compound to bind to the molecule or molecular complex. This invention also provides methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention provides methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to Aurora-2 or homologues thereof.
Abstract:
The present invention relates to compounds represented by the following structural formula: (I) useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of µsing the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
Abstract:
The present invention relates to compounds of formula (I) useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
Abstract:
The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.